耐多药结核病药物获取受限：行动呼吁。

Limited access to drugs for resistant tuberculosis: a call to action.

作者信息

Bélard Sabine, Janssen Saskia, Osbak Kara K, Adegnika Ayola A, Ondounda Magloire, Grobusch Martin P

机构信息

Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné BP118, Gabon Division of Internal Medicine, Centre of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam 1100 DD, The Netherlands Institute of Tropical Medicine, University of Tübingen, Tübingen 72074, Germany Department of Pediatric Pneumology and Immunology, Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.

出版信息

J Public Health (Oxf). 2015 Dec;37(4):691-3. doi: 10.1093/pubmed/fdu101. Epub 2014 Dec 19.

DOI:10.1093/pubmed/fdu101

PMID:25527468

Abstract

Although the rate of new tuberculosis (TB) cases has been falling worldwide, progress toward the targets for diagnosis and treatment of drug-resistant TB is far off-track. In countries with no reliable TB surveillance system, setbacks and progression of TB control is barely reflected and little is known on the situation in the field. Interviews with health professionals in Gabon revealed limited access to first- and second-line TB drugs and important deficiencies in basic TB control. National and international action needs to be taken to meet the global TB control targets.

摘要

尽管全球新增结核病病例数一直在下降，但在耐多药结核病的诊断和治疗目标方面进展却远远落后。在没有可靠结核病监测系统的国家，结核病控制的挫折和进展几乎得不到反映，对实地情况了解甚少。对加蓬卫生专业人员的访谈显示，一线和二线结核病药物的获取有限，基本结核病控制存在重大缺陷。需要采取国家和国际行动来实现全球结核病控制目标。